Request Deal Involvement
Merit Medical completed the acquiistion of the dialysis product portfolio and biosentry product from AngioDynamics for $100m.
Identify your role
Select the side you represented in this transaction, and provide your current job title.
Service Providers
financial advisors
Piper Sandler
financial advisors
Oppenheimer & Co
legal advisors
Parr Brown Gee & Loveless
pr advisors
Westwicke
legal advisors
Dorsey & Whitney
financial advisors
UBS
legal advisors
Cadwalader Wickersham & Taft
or
Principals
target
ANGIODYNAMICS (DIALYSIS PRODUCT PORTFOLIO AND BIOSENTRY PRODUCT)
bidder
MERIT MEDICAL SYSTEMS INC
vendor
ANGIODYNAMICS INC
Principals or Service Provider not listed?Add missing Service Provider or Principal
Enter your Job Title on this deal
This title will appear on your profile next to this deal involvement.
To help us verify your involvement, please include links to any relevant publications that mention you or your company's role in this deal:
All rights reserved. Copyright © 2025 Datasite